Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06357832 · ClinicalTrials.gov registry record · NA
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
A NA study, sponsored by Brainsway.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT06357832 is a NA study that has completed, run by Brainsway. The registered enrollment target is 104 participants.
The verdict
NCT06357832, a NA study, has completed, sponsored by Brainsway.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The BrainsWay Deep Transcranial Magnetic Stimulation (Depp TMS) device is intended for the treatment of depressive episodes in patients suffering from Major Depressive Disorder (MDD). The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a determined frequency. The purpose of the current study is to evaluate the safety and effectiveness of a new investigational stimulation protocol delivered with the BrainsWay Deep TMS device, for the treatment of MDD, demonstrating that it is non-inferior to the current standard-of-care stimulation protocol, in a randomized, controlled study.
Interventions
- DEVICE Brainsway Deep TMS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-04-29 |
| Est. Completion | 2026-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06357832
The ClinicalTrials.gov registry entry for NCT06357832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brainsway Deep TMS System is the first listed.
NCT06357832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06357832 about?
NCT06357832 is a clinical study titled "New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)". The BrainsWay Deep Transcranial Magnetic Stimulation (Depp TMS) device is intended for the treatment of depressive episodes in patients suffering from Major Depressive Disorder (MDD). The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a determi...
What is the current status of trial NCT06357832?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2024-04-29. Estimated completion is 2026-03-05.
What interventions are being tested in trial NCT06357832?
The interventions under investigation include: Brainsway Deep TMS System (DEVICE).
Who is sponsoring clinical trial NCT06357832?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.